Tabid, Dan Aiza .
HRN: 20-46-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/10/2023
CEFTRIAXONE 1G (VIAL)
05/10/2023
05/17/2023
IV
1.2gm
Q24
PCAP-B
Waiting Final Action
05/12/2023
CEFUROXIME 750MG (VIAL)
05/12/2023
05/18/2023
IVT
500 Mg
Q8
Urti
Waiting Final Action